Browsing Tag
Sun Pharmaceutical Industries Limited
7 posts
Who is really leading Indian pharma in 2026? The top 10 companies explained beyond the hype
Discover the top 10 pharma companies in India in 2026, who leads by revenue, reach, and strategy, and why the ranking is more complex than it looks.
Is Sun Pharmaceutical (NSE: SUNPHARMA) now a wait-for-results stock or an M&A rerating story?
Sun Pharmaceutical (NSE: SUNPHARMA) faces Q4 results, tariff risk, and the Organon bid. Read what could move the stock next.
Sun Pharmaceutical (NSE: SUNPHARMA) launches UNLOXCYT in U.S. for aCSCC
Sun Pharma's UNLOXCYT is now available in the U.S. for advanced CSCC. Find out how this checkpoint inhibitor could reshape skin cancer treatment today.
Biologics race in Indian pharma: Can Glenmark’s AbbVie tie-up spark a broader innovation moment?
India’s biologics race heats up as Glenmark, Biocon, Sun Pharma, Dr. Reddy’s, and Lupin push beyond generics—see how each strategy stacks up.
Sun Pharmaceutical faces regulatory pause as EMA application for melanoma drug withdrawn
Sun Pharmaceutical’s EU partner Philogen has withdrawn its EMA application for Nidlegy, delaying regulatory progress in melanoma care. Read what’s next.
Game-changer for knee pain? Sun Pharma’s MM-II injection delivers lasting relief, wins FDA fast track
Sun Pharma and Moebius report breakthrough in knee osteoarthritis treatment with MM-II. Learn how this new therapy could reshape pain management.
Sun Pharma reveals new clinical data at the 2024 EADV Congress, showing significant improvements in severe skin conditions
Sun Pharmaceutical Industries Limited has made a significant breakthrough in the treatment of severe dermatological conditions, unveiling new…